• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖及非酒精性脂肪性肝病患儿自身抗体血清阳性的意义

Significance of autoantibody seropositivity in children with obesity and non-alcoholic fatty liver disease.

作者信息

Yodoshi Toshifumi, Orkin Sarah, Arce-Clachar Ana Catalina, Bramlage Kristin, Xanthakos Stavra A, Mouzaki Marialena, Valentino Pamela L

机构信息

Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.

出版信息

Pediatr Obes. 2021 Jan;16(1):e12696. doi: 10.1111/ijpo.12696. Epub 2020 Jul 8.

DOI:10.1111/ijpo.12696
PMID:32638543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8006542/
Abstract

BACKGROUND

Autoantibodies are frequently positive in adults with nonalcoholic fatty liver disease (NAFLD) without concurrent autoimmune hepatitis (AIH). The clinical significance of this is unknown in children.

OBJECTIVE

To determine the prevalence of autoantibody positivity in pediatric NAFLD and to evaluate its association with disease severity.

METHODS

Multicenter, retrospective study of patients ≤18 years of age with biopsy-confirmed NAFLD. Descriptive statistics were used and groups were compared using Wilcoxon-Mann Whitney or χ testing, and multivariable logistic regression was used for binary or ordinal outcomes.

RESULTS

One hundred and thirty six patients with a median age of 14 years were included. The median body mass index Z-score was 2.5 (interquartile range 2.2, 2.6). Positive antinuclear antibody (ANA), anti-smooth muscle antibody (ASMA), anti-liver-kidney microsomal antibody, or any combination of autoantibodies were observed in 22%, 14%, 0%, and 33% of patients, respectively. The proportion of patients with a steatosis score ≥2 was significantly higher in those with positive ANA (P = .045). In the multivariable regression analysis, positive ANA was associated with increased odds of steatosis score ≥2 (odds ratio, 5.91; 95% confidential interval, 1.50-23.26), after controlling for potential confounders. No other significant histology differences were seen between the groups.

CONCLUSIONS

Positive ANA and ASMA are common in children with NAFLD; however, anti-LKM positivity is not. ANA positivity is associated with more severe steatosis.

摘要

背景

在无自身免疫性肝炎(AIH)并发的非酒精性脂肪性肝病(NAFLD)成人患者中,自身抗体常呈阳性。其在儿童中的临床意义尚不清楚。

目的

确定儿童NAFLD中自身抗体阳性的患病率,并评估其与疾病严重程度的关联。

方法

对年龄≤18岁且经活检确诊为NAFLD的患者进行多中心回顾性研究。采用描述性统计方法,使用Wilcoxon-Mann Whitney检验或χ²检验对组间进行比较,并使用多变量逻辑回归分析二元或有序结局。

结果

纳入了136例患者,中位年龄为14岁。中位体重指数Z评分为2.5(四分位间距2.2,2.6)。分别在22%、14%、0%和33%的患者中观察到抗核抗体(ANA)、抗平滑肌抗体(ASMA)、抗肝肾微粒体抗体或任何自身抗体组合呈阳性。ANA阳性患者中脂肪变性评分≥2的患者比例显著更高(P = 0.045)。在多变量回归分析中,在控制潜在混杂因素后,ANA阳性与脂肪变性评分≥2的几率增加相关(比值比,5.91;95%置信区间,1.50 - 23.26)。两组之间未观察到其他显著的组织学差异。

结论

ANA和ASMA阳性在NAFLD儿童中常见;然而,抗肝肾微粒体抗体阳性并不常见。ANA阳性与更严重的脂肪变性相关。

相似文献

1
Significance of autoantibody seropositivity in children with obesity and non-alcoholic fatty liver disease.肥胖及非酒精性脂肪性肝病患儿自身抗体血清阳性的意义
Pediatr Obes. 2021 Jan;16(1):e12696. doi: 10.1111/ijpo.12696. Epub 2020 Jul 8.
2
Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Nonalcoholic Fatty Liver Disease.超重和肥胖伴非酒精性脂肪性肝病儿童自身抗体的流行率及临床意义。
J Pediatr. 2021 Dec;239:155-160. doi: 10.1016/j.jpeds.2021.08.041. Epub 2021 Aug 27.
3
Autoimmune Antibodies in Children and Adolescents With Nonalcoholic Fatty Liver Disease.自身免疫抗体在非酒精性脂肪性肝病儿童和青少年中的研究
J Pediatr Gastroenterol Nutr. 2022 Sep 1;75(3):264-268. doi: 10.1097/MPG.0000000000003534. Epub 2022 Jun 27.
4
Association between positivity of serum autoantibodies and liver disease severity in patients with biopsy-proven NAFLD.在经肝活检证实的非酒精性脂肪性肝病患者中,血清自身抗体阳性与肝病严重程度之间存在关联。
Nutr Metab Cardiovasc Dis. 2021 Feb 8;31(2):552-560. doi: 10.1016/j.numecd.2020.10.004. Epub 2020 Oct 13.
5
Autoantibody Positivity Has No Impact on Histological Parameters in Nonalcoholic Fatty Liver Diseases.自身抗体阳性对非酒精性脂肪性肝病的组织学参数无影响。
J Clin Exp Hepatol. 2023 Sep-Oct;13(5):730-735. doi: 10.1016/j.jceh.2023.03.005. Epub 2023 Mar 17.
6
[A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcoholic fatty liver disease].[疑似非酒精性脂肪性肝病患者自身抗体患病率及临床意义的前瞻性研究]
Korean J Hepatol. 2005 Sep;11(3):261-7.
7
Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?在非酒精性脂肪性肝病中诊断自身免疫性肝炎:国际自身免疫性肝炎小组评分系统有用吗?
J Gastroenterol. 2005 Dec;40(12):1130-8. doi: 10.1007/s00535-005-1711-z.
8
Evaluation of frequency of autoimmune hepatitis autoantibodies in children with type 1 diabetes.1型糖尿病患儿自身免疫性肝炎自身抗体频率的评估。
Rev Gastroenterol Peru. 2019 Oct-Dec;39(4):344-347.
9
[Characteristics of clinical and laboratory indexes in patients with liver disease with positive anti-liver cytosol antibody].抗肝细胞溶质抗体阳性肝病患者的临床及实验室指标特征
Zhonghua Gan Zang Bing Za Zhi. 2021 Dec 20;29(12):1182-1187. doi: 10.3760/cma.j.cn501113-20210106-00009.
10
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.氧化型低密度脂蛋白抗体/高密度脂蛋白胆固醇比值与晚期非酒精性脂肪性肝病瘦患者有关。
J Gastroenterol Hepatol. 2016 Sep;31(9):1611-8. doi: 10.1111/jgh.13335.

引用本文的文献

1
Activated Immune and Complement C3 Are Potential Contributors in MASH via Stimulating Neutrophil Extracellular Traps.活化的免疫细胞和补体C3通过刺激中性粒细胞胞外诱捕网,可能在重症急性肾损伤中发挥作用。
Cells. 2025 May 19;14(10):740. doi: 10.3390/cells14100740.
2
Association of antinuclear antibody positivity with liver disease severity in pediatric metabolic dysfunction-associated steatotic liver disease.儿童代谢功能障碍相关脂肪性肝病中抗核抗体阳性与肝脏疾病严重程度的关联
Front Pediatr. 2025 Feb 26;13:1527605. doi: 10.3389/fped.2025.1527605. eCollection 2025.
3
Detection of polyreactive immunoglobulin G facilitates diagnosis in children with autoimmune hepatitis.

本文引用的文献

1
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases.成人和儿童自身免疫性肝炎的诊断与管理:美国肝病研究协会2019年实践指南与规范
Hepatology. 2020 Aug;72(2):671-722. doi: 10.1002/hep.31065. Epub 2020 May 12.
2
Analysis of human leukocyte antigen allele polymorphism in patients with non alcoholic fatty liver disease.非酒精性脂肪性肝病患者人类白细胞抗原等位基因多态性分析
Medicine (Baltimore). 2019 Aug;98(32):e16704. doi: 10.1097/MD.0000000000016704.
3
Psychotropic Medications Are Associated With Increased Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease.
多反应性免疫球蛋白 G 的检测有助于儿童自身免疫性肝炎的诊断。
Hepatol Int. 2024 Aug;18(4):1214-1226. doi: 10.1007/s12072-024-10695-1. Epub 2024 Jul 8.
4
Applicability of International Autoimmune Hepatitis Group (IAIHG) Scoring System for Autoimmune Hepatitis in Pediatrics.国际自身免疫性肝炎小组(IAIHG)评分系统在儿童自身免疫性肝炎中的适用性
Biology (Basel). 2023 Mar 21;12(3):479. doi: 10.3390/biology12030479.
5
Prevalence and Significance of Autoantibody Seropositivity in Children with Wilson's Disease.肝豆状核变性患儿自身抗体血清阳性的患病率及意义
Diagnostics (Basel). 2023 Feb 17;13(4):768. doi: 10.3390/diagnostics13040768.
6
Prevalence and Significance of Antinuclear Antibodies in Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.在经活检证实的非酒精性脂肪性肝病中抗核抗体的流行率和意义:系统评价和荟萃分析。
Dis Markers. 2022 Aug 12;2022:8446170. doi: 10.1155/2022/8446170. eCollection 2022.
精神药物与儿童非酒精性脂肪性肝病的肝脏疾病严重程度增加有关。
J Pediatr Gastroenterol Nutr. 2019 Sep;69(3):339-343. doi: 10.1097/MPG.0000000000002401.
4
Juvenile autoimmune hepatitis: A comprehensive review.青少年自身免疫性肝炎:全面综述。
J Autoimmun. 2018 Dec;95:69-76. doi: 10.1016/j.jaut.2018.10.007. Epub 2018 Oct 19.
5
Translocation of a gut pathobiont drives autoimmunity in mice and humans.肠道共生病原体易位导致小鼠和人类发生自身免疫。
Science. 2018 Mar 9;359(6380):1156-1161. doi: 10.1126/science.aar7201.
6
NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).NASPGHAN儿童非酒精性脂肪性肝病诊断与治疗临床实践指南:非酒精性脂肪性肝病专家委员会(ECON)及北美儿科胃肠病学、肝病学和营养学会(NASPGHAN)的建议
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):319-334. doi: 10.1097/MPG.0000000000001482.
7
Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children.成人及儿童非酒精性脂肪性肝病和非酒精性脂肪性肝炎的组织学
Clin Liver Dis. 2016 May;20(2):293-312. doi: 10.1016/j.cld.2015.10.011. Epub 2015 Dec 28.
8
EASL Clinical Practice Guidelines: Autoimmune hepatitis.欧洲肝脏研究学会临床实践指南:自身免疫性肝炎
J Hepatol. 2015 Oct;63(4):971-1004. doi: 10.1016/j.jhep.2015.06.030. Epub 2015 Sep 1.
9
Autoimmune Markers Do Not Impact Clinical Presentation or Natural History of Steatohepatitis-Related Liver Disease.自身免疫标志物不影响脂肪性肝炎相关肝病的临床表现或自然病程。
Dig Dis Sci. 2015 Dec;60(12):3788-93. doi: 10.1007/s10620-015-3795-5. Epub 2015 Jul 15.
10
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.肝纤维化而非其他组织学特征与非酒精性脂肪性肝病患者的长期预后相关。
Gastroenterology. 2015 Aug;149(2):389-97.e10. doi: 10.1053/j.gastro.2015.04.043. Epub 2015 Apr 29.